 |
Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor |
|---|---|
| Trade Name | |
| Orphan Indication | Acute lymphoblastic leukaemia |
| EU Market Approval | EU |
| EU Designation Date | 2015-11-11 00:00:00 |
| Sponsor | Kite Pharma EU B.V. |
